Fortunesoft IT Innovations was founded over 17 years ago and is headquartered at Koramangala, Bengaluru, Karnataka, India, with additional offices in Nashville, Tennessee (United States), Sydney, Australia, Singapore, and Nairobi, Kenya. The company operates as a full-cycle software engineering and technology services firm serving two primary industry verticals — life sciences and healthcare, alongside fintech — with a broader portfolio of digital transformation, AI, and product engineering services.

Within the life sciences sector, Fortunesoft positions itself as a domain-specialist technology partner capable of designing, building, validating, and maintaining software systems across the full drug development and manufacturing lifecycle, from drug discovery and R&D informatics through to clinical operations, laboratory management, manufacturing execution, and regulatory submissions. The company’s stated compliance competencies span FDA 21 CFR Part 11, GxP (GMP, GCP, GLP), GAMP 5, ICH Guidelines, HIPAA, ISO 13485, ISO 27001, and SOC 2 — a breadth of regulatory framework coverage that reflects the diversity of its target client environments.

The company reports over 150 clients, 510 completed projects, and more than 2,400 successful development sprints across its operational history. Its client base spans pharmaceutical companies, biotechnology organisations, CROs, CDMOs, medical device manufacturers, life sciences start-ups, and healthcare-life sciences hybrid enterprises. Fortunesoft delivers software development using agile methodologies, with engagement models available on a project basis, via dedicated team arrangements, or as long-term managed support partnerships.

Key Products and Services

Life Sciences Software Development

• Custom life sciences software development — bespoke applications supporting research, clinical, laboratory, manufacturing, and regulatory workflows, engineered to GxP and relevant regulatory standards
• Life sciences product modernisation — re-platforming of legacy systems to cloud-native, secure, and compliant architectures
• Process automation and workflow optimisation — intelligent automation of R&D, clinical, and operational processes to improve throughput and reduce manual burden
• Data integration and platform engineering — unification of siloed data sources and development of data pipelines for real-time analytics and reporting
• Quality engineering and validation — rigorous software testing, verification, and validation documentation aligned with GxP, GAMP 5, and global regulatory expectations
• API development and system interoperability — integration across LIMS, ELN, EDC, CTMS, MES, ERP, and other critical life sciences platforms

Domain-Specific System Coverage

• Drug Discovery and Omics — platforms supporting research workflow, data quality, and cross-team scientific collaboration in discovery and omics programmes
• Clinical Trial Systems — EDC, CTMS, eTMF, ePRO, and randomisation systems; compliant digital infrastructure for trial oversight, participant management, monitoring, and reporting
• Clinical Intelligence — data analytics and business intelligence applications for clinical operations
• Laboratory Systems — LIMS and ELN development, instrument integration, sample management, and automated QC workflow support
• Medical Device Software — software development aligned with ISO 13485 and medical device QMS requirements
• Pharma and Safety Systems — pharmacovigilance, drug safety, regulatory submission, and quality management system applications; batch management, traceability, and supply chain orchestration

AI and Agentic AI Services

• Agentic AI engineering — autonomous, multi-agent AI systems designed to execute complex, multi-step tasks within life sciences and clinical operations workflows
• Vertical AI consulting — domain-specific AI strategy and implementation combining agentic intelligence with life sciences knowledge in EHR, clinical operations, regulatory technology, and related areas
• LLM toolchains and production systems — integration of large language models, secure Retrieval Augmented Generation (RAG) pipelines, and AI components into regulated life sciences environments

Compliance and Validation Engineering

• GxP-aligned software validation — Computer System Validation (CSV) documentation, IQ/OQ/PQ protocols, and GAMP 5 risk-based validation frameworks
• FDA 21 CFR Part 11 controls — audit trails, electronic records and signatures, and role-based access controls built into application architecture
• ISO 27001 and SOC 2 security controls — enterprise-grade information security management and cloud security architecture

Fortunesoft IT Innovations occupies the technology services segment of the life sciences sector as a software development partner rather than a CRO, CDMO, or clinical services provider. Its value proposition to life sciences clients rests on the combination of GxP regulatory compliance expertise — which differentiates it from generic IT services firms — and full-cycle development capability spanning custom build, legacy modernisation, AI integration, and ongoing support. The company’s offshore-anchored, multi-geography delivery model (Bengaluru headquarters with US, Australia, Singapore, and Kenya offices) provides a cost structure accessible to smaller life sciences companies and start-ups alongside larger pharmaceutical and biotech organisations. The addition of agentic AI services reflects a strategic alignment with the pharmaceutical industry’s growing investment in AI-enabled clinical and research operations, though the company’s published case studies draw predominantly from healthcare and fintech contexts rather than regulated pharmaceutical settings, suggesting that life sciences-specific AI delivery experience may still be developing.